Sixue Xing

Ling Yue, Sixue Xing, Jintai Chen et al.

Clinical trials need to recruit a sufficient number of volunteer patients to demonstrate the statistical power of the treatment (e.g., a new drug) in curing a certain disease. Clinical trial recruitment has a significant impact on trial success. Forecasting whether the recruitment process would be successful before we run the trial would save many resources and time. This paper develops a novel deep & cross network with large language model (LLM)-augmented text feature that learns semantic information from trial eligibility criteria and predicts enrollment success. The proposed method enables interpretability by understanding which sentence/word in eligibility criteria contributes heavily to prediction. We also demonstrate the empirical superiority of the proposed method (0.7002 PR-AUC) over a bunch of well-established machine learning methods. The code and curated dataset are publicly available at https://anonymous.4open.science/r/TrialEnroll-7E12.

Sixue Xing, Xuanye Xia, Kerui Wu et al.

Clinical trial failure remains a central bottleneck in drug development, where minor protocol design flaws can irreversibly compromise outcomes despite promising therapeutics. Although cutting-edge AI methods achieve strong performance in predicting trial success, they are inherently reactive for merely diagnosing risk without offering actionable remedies once failure is anticipated. To fill this gap, this paper proposes ClinicalReTrial, a self-evolving AI agent framework that addresses this gap by casting clinical trial reasoning as an iterative protocol redesign problem. Our method integrates failure diagnosis, safety-aware modification, and candidate evaluation in a closed-loop, reward-driven optimization framework. Serving the outcome prediction model as a simulation environment, ClinicalReTrial enables low-cost evaluation of protocol modifications and provides dense reward signals for continuous self-improvement. To support efficient exploration, the framework maintains hierarchical memory that captures iteration-level feedback within trials and distills transferable redesign patterns across trials. Empirically, ClinicalReTrial improves 83.3% of trial protocols with a mean success probability gain of 5.7%, and retrospective case studies demonstrate strong alignment between the discovered redesign strategies and real-world clinical trial modifications.

Kushal Raj Bhandari, Sixue Xing, Soham Dan et al.

Large Language Models (LLMs), already shown to ace various unstructured text comprehension tasks, have also remarkably been shown to tackle table (structured) comprehension tasks without specific training. Building on earlier studies of LLMs for tabular tasks, we probe how in-context learning (ICL), model scale, instruction tuning, and domain bias affect Tabular QA (TQA) robustness by testing LLMs, under diverse augmentations and perturbations, on diverse domains: Wikipedia-based $\textbf{WTQ}$, financial $\textbf{TAT-QA}$, and scientific $\textbf{SCITAB}$. Although instruction tuning and larger, newer LLMs deliver stronger, more robust TQA performance, data contamination and reliability issues, especially on $\textbf{WTQ}$, remain unresolved. Through an in-depth attention analysis, we reveal a strong correlation between perturbation-induced shifts in attention dispersion and the drops in performance, with sensitivity peaking in the model's middle layers. We highlight the need for improved interpretable methodologies to develop more reliable LLMs for table comprehension. Through an in-depth attention analysis, we reveal a strong correlation between perturbation-induced shifts in attention dispersion and performance drops, with sensitivity peaking in the model's middle layers. Based on these findings, we argue for the development of structure-aware self-attention mechanisms and domain-adaptive processing techniques to improve the transparency, generalization, and real-world reliability of LLMs on tabular data.